The US government is on the verge of finalizing an agreement to finance a late-stage trial for Moderna's mRNA pandemic bird flu vaccine, according to a recent report from the Financial Times.

The U.S. government is closing in on a deal to fund a late-stage trial for an mRNA pandemic bird flu vaccine made by Moderna, the Financial Times reported Thursday, at a time when the country is ...